# Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation

> **NCT02852434** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 72 (actual)

## Conditions studied

- Pain Management, Cervical Preparation

## Interventions

- **DRUG:** Lidocaine Gel (2%)
- **DRUG:** Lidocaine Paracervical Block (1%)

## Key facts

- **NCT ID:** NCT02852434
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02852434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02852434, "Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02852434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
